Aap Implantate AG Reports Strong Growth in Q3 2025

aap Implantate AG announced a 15% sales increase in the third quarter of 2025 compared to the same quarter last year. The LOQTEQ® portfolio gained significant traction globally, particularly enhancing user interest due to its technical advantages. Sales were strongest in the APAC region, which saw a remarkable 204% increase. North America and LATAM regions recorded growths of 18% and 21%, respectively. Meanwhile, EMEA saw a 5% rise, with notable performance in Spain and Portugal.

Despite production and supply challenges, aap enters Q4 with an order backlog valued at around EUR 400,000. The company is optimistic about further sales base strengthening, supported by ongoing expansion and market penetration strategies. Cumulative sales for the first nine months of 2025 reached EUR 9.48 million, surpassing the previous year's figure by 2%.